Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2150836017 | Efalizumab (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 2158640011 | Efalizumab | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3522560012 | Product containing efalizumab (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3522561011 | Product containing efalizumab | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3667049015 | Efalizumab product | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3714600019 | Efalizumab-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Efalizumab-containing product | Is a | Monoclonal antibody-containing product | true | Inferred relationship | Some | ||
| Efalizumab-containing product | Has active ingredient | Efalizumab | true | Inferred relationship | Some | 1 | |
| Efalizumab-containing product | Has active ingredient | Immunosuppressant | false | Inferred relationship | Some | ||
| Efalizumab-containing product | Is a | Immunomodulator-containing product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Efalizumab only product | Is a | True | Efalizumab-containing product | Inferred relationship | Some | |
| Raptiva | Is a | False | Efalizumab-containing product | Inferred relationship | Some | |
| Efalizumab 125mg/vial lyophilised powder for injection | Is a | False | Efalizumab-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR